Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Ascend update very soon before or after news FDA V4.0 ?🚀
View:
Post by jopatclo on Jul 11, 2024 12:58pm

Ascend update very soon before or after news FDA V4.0 ?🚀

good comment and see  beautiful picture on thie post Learn more about our imaging workflows here:
https://lnkd.in/gDMsFGff
 With the VentriPoint integration,
@cardinal Where is thee sales and demo team this week.
 
9
from #vpt, 
 
@cardinal Should hear Ascend update very soon
 
10
from #vpt, 

Open Integration with specialized AI algorithms

  • Seamlessly integrate specialized AI algorithms with our diagnostic viewer, InView, to improve diagnosis and monitoring of fetal, pediatric, and adult congenital heart disease
  • With the VentriPoint integration, generate 3D models of the heart’s chambers from Echo imaging for reproducible and accurate volumetric measurements and ejection fractions
VentriPoint-screenshot
Comment by jopatclo on Jul 12, 2024 8:18am
Remenber interesting on Ascend Cardiovascular on website Ventripoint comment “Our goal is that, by working together, we can provide reliable and effective tools to clinicians globally. » Dr. Jeffrey Soble CEO ASCEND   and see reactionon post Ascend Cardiovascular  Kevin Sekula     Advanced Product Specialist - Invasive Cardiology ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities